Tonix Pharm Holdings (TNXP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,249 | 25,034 | 25,496 | 18,941 | 19,175 |
| Marketable Securities | N/A | N/A | N/A | 7,180 | 23,841 |
| TOTAL | $13,948 | $26,056 | $26,443 | $27,140 | $46,359 |
| Non-Current Assets | |||||
| PPE Net | 34 | 43 | 91 | 150 | 350 |
| Intangibles | 120 | 120 | 120 | 120 | 120 |
| Other Non-Current Assets | 456 | 100 | 100 | 100 | 189 |
| TOTAL | $610 | $263 | $311 | $370 | $659 |
| Total Assets | $14,558 | $26,319 | $26,754 | $27,510 | $47,018 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,070 | 1,404 | 1,296 | 872 | 3,049 |
| Accrued Expenses | 1,713 | 1,251 | 830 | 1,244 | 3,601 |
| TOTAL | $5,135 | $2,655 | $2,126 | $2,116 | $6,650 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6 | 0 | 0 | 0 | 0 |
| TOTAL | $6 | $N/A | $12 | $33 | $106 |
| Total Liabilities | $5,141 | $2,655 | $2,138 | $2,149 | $6,756 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 49,353 | 6,090 | 7,831 | 7,486 | 18,873 |
| Common Shares | 9 | N/A | 1 | 4 | 2 |
| Retained earnings | -217,070 | -188,452 | -162,363 | -141,240 | -102,398 |
| Other shareholders' equity | -46 | -41 | -12 | -7 | -17 |
| TOTAL | $9,417 | $23,664 | $24,616 | $25,361 | $40,262 |
| Total Liabilities And Equity | $14,558 | $26,319 | $26,754 | $27,510 | $47,018 |